• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于脂质纳米颗粒的 mRNA 疫苗生物工艺的比较研究与机器学习和组合人工神经网络-实验设计方法。

Comparative study of lipid nanoparticle-based mRNA vaccine bioprocess with machine learning and combinatorial artificial neural network-design of experiment approach.

机构信息

BK21 FOUR Team and Integrated Research Institute for Drug Development, College of Pharmacy, Dongguk University, Gyeonggi 10326, Republic of Korea.

CKD Pharm Corp., Hyo-Jong Research Institute, Gyeonggi 16995, Republic of Korea.

出版信息

Int J Pharm. 2023 Jun 10;640:123012. doi: 10.1016/j.ijpharm.2023.123012. Epub 2023 May 2.

DOI:10.1016/j.ijpharm.2023.123012
PMID:37142140
Abstract

To develop a combinatorial artificial-neural-network design-of-experiment (ANN-DOE) model, the effect of ionizable lipid, an ionizable lipid-to-cholesterol ratio, N/P ratio, flow rate ratio (FRR), and total flow rate (TFR) on the outcome responses of mRNA-LNP vaccine were evaluated using a definitive screening design (DSD) and machine learning (ML) algorithms. Particle size (PS), PDI, zeta potential (ZP), and encapsulation efficiency (EE) of mRNA-LNP were optimized within a defined constraint (PS 40-100 nm, PDI ≤ 0.30, ZP≥(±)0.30 mV, EE ≥ 70 %), fed to ML algorithms (XGBoost, bootstrap forest, support vector machines, k-nearest neighbors, generalized regression-Lasso, ANN) and prediction was compared to ANN-DOE model. Increased FRR decreased the PS and increased ZP, while increased TFR increased PDI and ZP. Similarly, DOTAP and DOTMA produced higher ZP and EE. Particularly, a cationic ionizable lipid with an N/P ratio ≥ 6 provided a higher EE. ANN showed better predictive ability (R = 0.7269-0.9946), while XGBoost demonstrated better RASE (0.2833-2.9817). The ANN-DOE model outperformed both optimized ML models by R = 1.21 % and RASE = 43.51 % (PS prediction), R = 0.23 % and RASE = 3.47 % (PDI prediction), R = 5.73 % and RASE = 27.95 % (ZP prediction), and R = 0.87 % and RASE = 36.95 % (EE prediction), respectively, which demonstrated that ANN-DOE model was superior in predicting the bioprocess compared to independent models.

摘要

为了开发组合人工神经网络实验设计(ANN-DOE)模型,使用确定筛选设计(DSD)和机器学习(ML)算法评估可离子化脂质、可离子化脂质与胆固醇的比例、N/P 比、流速比(FRR)和总流速(TFR)对 mRNA-LNP 疫苗结果的影响。在限定的约束条件(PS 40-100nm、PDI≤0.30、ZP≥(±)0.30mV、EE≥70%)内优化了 mRNA-LNP 的粒径(PS)、多分散指数(PDI)、Zeta 电位(ZP)和包封效率(EE),并将其输入到 ML 算法(XGBoost、自举森林、支持向量机、k-最近邻、广义回归-Lasso、ANN)中进行预测,并与 ANN-DOE 模型进行比较。增加 FRR 会降低 PS 并增加 ZP,而增加 TFR 会增加 PDI 和 ZP。同样,DOTAP 和 DOTMA 产生更高的 ZP 和 EE。特别是,N/P 比≥6 的阳离子可离子化脂质提供了更高的 EE。ANN 表现出更好的预测能力(R=0.7269-0.9946),而 XGBoost 则表现出更好的 RASE(0.2833-2.9817)。ANN-DOE 模型在 PS 预测中通过 R=1.21%和 RASE=43.51%、PDI 预测中通过 R=0.23%和 RASE=3.47%、ZP 预测中通过 R=5.73%和 RASE=27.95%、EE 预测中通过 R=0.87%和 RASE=36.95%,分别优于这两个优化后的 ML 模型,这表明 ANN-DOE 模型在预测生物过程方面优于独立模型。

相似文献

1
Comparative study of lipid nanoparticle-based mRNA vaccine bioprocess with machine learning and combinatorial artificial neural network-design of experiment approach.基于脂质纳米颗粒的 mRNA 疫苗生物工艺的比较研究与机器学习和组合人工神经网络-实验设计方法。
Int J Pharm. 2023 Jun 10;640:123012. doi: 10.1016/j.ijpharm.2023.123012. Epub 2023 May 2.
2
Development of fucoidan/polyethyleneimine based sorafenib-loaded self-assembled nanoparticles with machine learning and DoE-ANN implementation: Optimization, characterization, and in-vitro assessment for the anticancer drug delivery.基于机器学习和 DOE-ANN 实现的岩藻多糖/聚乙烯亚胺载索拉非尼自组装纳米粒的研制:抗癌药物输送的优化、表征和体外评估。
Int J Biol Macromol. 2024 Nov;279(Pt 1):135123. doi: 10.1016/j.ijbiomac.2024.135123. Epub 2024 Aug 27.
3
Microfluidic Manufacturing of Liposomes: Development and Optimization by Design of Experiment and Machine Learning.微流控制造脂质体:通过实验设计和机器学习进行开发和优化。
ACS Appl Mater Interfaces. 2022 Sep 7;14(35):39736-39745. doi: 10.1021/acsami.2c06627. Epub 2022 Aug 24.
4
Design of experiment (DOE) applied to artificial neural network architecture enables rapid bioprocess improvement.设计实验(DOE)应用于人工神经网络结构可实现快速生物工艺改进。
Bioprocess Biosyst Eng. 2021 Jun;44(6):1301-1308. doi: 10.1007/s00449-021-02529-3. Epub 2021 Feb 27.
5
Prediction of lipid nanoparticles for mRNA vaccines by the machine learning algorithm.通过机器学习算法预测用于mRNA疫苗的脂质纳米颗粒。
Acta Pharm Sin B. 2022 Jun;12(6):2950-2962. doi: 10.1016/j.apsb.2021.11.021. Epub 2021 Dec 2.
6
Characterization of Lipid Nanoparticles Containing Ionizable Cationic Lipids Using Design-of-Experiments Approach.采用实验设计方法对含可离子化阳离子脂质的脂质纳米粒子进行表征。
Langmuir. 2021 Jan 26;37(3):1120-1128. doi: 10.1021/acs.langmuir.0c03039. Epub 2021 Jan 13.
7
Formulation design and optimization of cationic-charged liposomes of brimonidine tartrate for effective ocular drug delivery by design of experiment (DoE) approach.通过实验设计 (DoE) 方法设计酒石酸溴莫尼定阳离子脂质体的配方并进行优化,以实现有效的眼部药物传递。
Drug Dev Ind Pharm. 2021 Nov;47(11):1847-1866. doi: 10.1080/03639045.2022.2070198. Epub 2022 May 19.
8
A comparative evaluation of the generalised predictive ability of eight machine learning algorithms across ten clinical metabolomics data sets for binary classification.八种机器学习算法在十个临床代谢组学数据集上进行二进制分类的广义预测能力的比较评估。
Metabolomics. 2019 Nov 15;15(12):150. doi: 10.1007/s11306-019-1612-4.
9
Do we need different machine learning algorithms for QSAR modeling? A comprehensive assessment of 16 machine learning algorithms on 14 QSAR data sets.我们是否需要不同的机器学习算法来进行定量构效关系建模?对 16 种机器学习算法在 14 个定量构效关系数据集上的综合评估。
Brief Bioinform. 2021 Jul 20;22(4). doi: 10.1093/bib/bbaa321.
10
Development of Machine Learning Model for Prediction of Demolition Waste Generation Rate of Buildings in Redevelopment Areas.开发用于预测重建区建筑物拆除废物产生率的机器学习模型。
Int J Environ Res Public Health. 2022 Dec 21;20(1):107. doi: 10.3390/ijerph20010107.

引用本文的文献

1
Artificial Intelligence-Driven Strategies for Targeted Delivery and Enhanced Stability of RNA-Based Lipid Nanoparticle Cancer Vaccines.基于人工智能的策略用于靶向递送和增强基于RNA的脂质纳米颗粒癌症疫苗的稳定性
Pharmaceutics. 2025 Jul 30;17(8):992. doi: 10.3390/pharmaceutics17080992.
2
Microfluidic Platforms for Ex Vivo and In Vivo Gene Therapy.用于体外和体内基因治疗的微流控平台
Biosensors (Basel). 2025 Aug 4;15(8):504. doi: 10.3390/bios15080504.
3
Enhancing nucleic acid delivery by the integration of artificial intelligence into lipid nanoparticle formulation.
通过将人工智能整合到脂质纳米颗粒制剂中来增强核酸递送。
Front Med Technol. 2025 Jun 16;7:1591119. doi: 10.3389/fmedt.2025.1591119. eCollection 2025.
4
Machine Learning-Enhanced Nanoparticle Design for Precision Cancer Drug Delivery.用于精准癌症药物递送的机器学习增强型纳米颗粒设计
Adv Sci (Weinh). 2025 Aug;12(30):e03138. doi: 10.1002/advs.202503138. Epub 2025 Jun 19.
5
The application of machine learning in clinical microbiology and infectious diseases.机器学习在临床微生物学和传染病中的应用。
Front Cell Infect Microbiol. 2025 May 1;15:1545646. doi: 10.3389/fcimb.2025.1545646. eCollection 2025.
6
Revolutionizing immunization: a comprehensive review of mRNA vaccine technology and applications.免疫接种的变革:mRNA疫苗技术与应用的全面综述
Virol J. 2025 Mar 12;22(1):71. doi: 10.1186/s12985-025-02645-6.
7
Computational Methods for Modeling Lipid-Mediated Active Pharmaceutical Ingredient Delivery.脂质介导的活性药物成分递送建模的计算方法
Mol Pharm. 2025 Mar 3;22(3):1110-1141. doi: 10.1021/acs.molpharmaceut.4c00744. Epub 2025 Jan 29.
8
Machine learning-driven optimization of mRNA-lipid nanoparticle vaccine quality with XGBoost/Bayesian method and ensemble model approaches.基于XGBoost/贝叶斯方法和集成模型方法的机器学习驱动的mRNA-脂质纳米颗粒疫苗质量优化
J Pharm Anal. 2024 Nov;14(11):100996. doi: 10.1016/j.jpha.2024.100996. Epub 2024 May 8.
9
Composition of lipid nanoparticles for targeted delivery: application to mRNA therapeutics.用于靶向递送的脂质纳米颗粒的组成:在mRNA治疗中的应用。
Front Pharmacol. 2024 Oct 23;15:1466337. doi: 10.3389/fphar.2024.1466337. eCollection 2024.
10
Machine Learning Elucidates Design Features of Plasmid Deoxyribonucleic Acid Lipid Nanoparticles for Cell Type-Preferential Transfection.机器学习阐明了质粒脱氧核糖核酸脂质纳米颗粒用于细胞类型选择性转染的设计特征。
ACS Nano. 2024 Oct 22;18(42):28735-28747. doi: 10.1021/acsnano.4c07615. Epub 2024 Oct 7.